parthenolide has been researched along with Cancer of Cervix in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Gao, D; Gao, W; Li, C; Li, L; Li, Z; Wei, S; Zhang, X | 1 |
Arockiam, AJ; Jeyamohan, S; Kannan, MK; Moorthy, RK | 1 |
Chen, F; Haley-Zitlin, V; He, G; Huang, G; Kim, HJ; Rushing, JW; Wang, X; Wu, C | 1 |
3 other study(ies) available for parthenolide and Cancer of Cervix
Article | Year |
---|---|
Nano magnetic liposomes-encapsulated parthenolide and glucose oxidase for ultra-efficient synergistic antitumor therapy.
Topics: Administration, Intravenous; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Compounding; Drug Synergism; Female; Glucose Oxidase; Glutathione; HeLa Cells; Humans; Liposomes; Magnetite Nanoparticles; Mice; Sesquiterpenes; Tumor Microenvironment; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Parthenolide induces apoptosis and autophagy through the suppression of PI3K/Akt signaling pathway in cervical cancer.
Topics: Apoptosis; Autophagy; Female; HeLa Cells; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction; Uterine Cervical Neoplasms | 2016 |
Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apigenin; Breast Neoplasms; Camphor; Cell Division; Cell Line, Tumor; Drug Synergism; Female; Humans; Luteolin; Neoplasms; Plant Extracts; Sesquiterpenes; Tanacetum parthenium; Uterine Cervical Neoplasms | 2006 |